Lamictal CD

See also: Generic Lamictal, Generic Lamictal ODT, Generic Lamictal XR

Lamictal CD is a brand name of lamotrigine, approved by the FDA in the following formulation(s):

LAMICTAL CD (lamotrigine - tablet, chewable; oral)

• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: August 24, 1998
  
  Strength(s): 25MG ^[RLD][AB], 5MG ^[AB]


• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: September 8, 2000
  
  Strength(s): 2MG ^[AB]

Has a generic version of Lamictal CD been approved?

A generic version of Lamictal CD has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Lamictal CD and have been approved by the FDA:

lamotrigine tablet, chewable; oral

• 
  Manufacturer: AUROBINDO PHARMA
  
  Approval date: November 4, 2009
  
  Strength(s): 25MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: DR REDDYS LABS LTD
  
  Approval date: January 22, 2009
  
  Strength(s): 25MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: GLENMARK GENERICS
  
  Approval date: February 19, 2009
  
  Strength(s): 25MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: JUBILANT LIFE
  
  Approval date: February 28, 2011
  
  Strength(s): 25MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: January 22, 2009
  
  Strength(s): 25MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: TARO
  
  Approval date: February 4, 2009
  
  Strength(s): 25MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: June 21, 2006
  
  Strength(s): 25MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: January 22, 2009
  
  Strength(s): 25MG ^[AB], 2MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: ZYDUS PHARMS USA INC
  
  Approval date: January 22, 2009
  
  Strength(s): 25MG ^[AB], 5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lamictal CD. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Water-dispersible tablets
  Patent 5,698,226
  Issued: December 16, 1997
  Inventor(s): Fielden; Krystyna Elzbieta
  Assignee(s): Glaxo Wellcome Inc.
  A water-dispersible tablet comprises an active compound such as acyclovir or lamotrigine and a dispersing agent. The dispersing agent is a swellable clay such as a smectite, e.g. Veegum F or bentonite, and is generally present within the granules of the tablet to provide a tablet which is capable of dispersing in water within 3 minutes to provide a dispersion which will pass through a 710 .mu.m sieve. The tablet can be optionally film-coated in which case the dispersion time is less than 5 minutes.
  
  Patent expiration dates:
  
  
  • January 29, 2012
    
  
  
  
  • July 29, 2012
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Lamictal CD Advanced Consumer Information (Micromedex)
• Lamotrigine Consumer Information (Wolters Kluwer)
• Lamotrigine Chewable Dispersible Tablets Consumer Information (Wolters Kluwer)
• Lamotrigine Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Lamotrigine Orally Disintegrating Tablets Consumer Information (Wolters Kluwer)
• Lamotrigine Consumer Information (Cerner Multum)
• Lamotrigine Advanced Consumer Information (Micromedex)
• Lamotrigine AHFS DI Monographs (ASHP)